{{Rsnum
|rsid=3861950
|Gene=TNFSF4
|Chromosome=1
|position=173187153
|Orientation=plus
|GMAF=0.3898
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=TNFSF4
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 46.9 | 46.0
| HCB | 1.5 | 20.4 | 78.1
| JPT | 0.9 | 12.4 | 86.7
| YRI | 79.5 | 19.2 | 1.4
| ASW | 59.6 | 36.8 | 3.5
| CHB | 1.5 | 20.4 | 78.1
| CHD | 0.9 | 19.3 | 79.8
| GIH | 6.9 | 45.5 | 47.5
| LWK | 79.6 | 17.6 | 2.8
| MEX | 8.8 | 49.1 | 42.1
| MKK | 44.2 | 48.1 | 7.7
| TSI | 12.7 | 50.0 | 37.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=21402531
|Title=[Association study between TNFSF4 and coronary heart disease]
}}

{{PMID|21445270|OA=1
}} A common polymorphism in the promoter region of the TNFSF4 gene is associated with lower allele-specific expression and risk of myocardial infarction.

{{PMID Auto
|PMID=23184501
|Title=TNFSF4 gene polymorphism rs3861950 but not rs3850641 is associated with the risk of cerebral infarction in a Chinese population
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}